← All verdicts
Verdict

Deep Undervalued

Every analyzed stock in Deep Undervalued — 1,156 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Deep Undervalued" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 3.1% below its 1-year high (as of 2026-09-16). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 7.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Proxy: price-to-book ≤ 0.8 (our deep-undervalued band has no point-in-time history yet) · bought the day of the annual report, held 12 months
Robust Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +23.6 pts (608 entries, 188 companies, very unlikely to be luck). 57% of entries beat the S&P; 30% beat it by 30 points or more; 25% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +21.9 pts.
+23.6 ptsvs S&P, average
57%beat the S&P
30%up 30+ pts vs S&P
25%down 20+ pts vs S&P
+24.1 ptsvs small caps, 12 mo
−16.1 pts 2023worst year to buy ?
6.0luck check ?
Does the holding period matter?3 mo: +4.9 pts 52% beat6 mo: +9.1 pts 54% beat12 mo: +23.6 pts 57% beat24 mo: +35.1 pts 52% beat3 yr, per yr: +6.5 pts 46% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today522+15.2 pts t 5.1+16.9 pts
Sell-off (S&P ≥10% off high)86+74.7 pts t 3.7+67.9 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing195+23.5 pts t 4.1+3.4 pts
Other64+13.8 pts t 2.0+9.3 pts
Tech hardware & semis54+14.9 pts t 1.1+2.6 pts
Energy51+27.4 pts t 2.0+4.8 pts
Retail & consumer33+33.7 pts t 2.2+21.4 pts
Services33+13.4 pts t 2.1+18.5 pts
Construction28+19.9 pts t 2.0+3.7 pts
Finance & real estate28+4.9 pts t 0.7+3.1 pts

Holds up out of sample? Before 2018: +17.1 pts (n 274, t 5.9). From 2018: +29.0 pts (n 334, t 4.3). Same sign in both halves.

Year2010201120122013201420152016201720182019202020212022202320242025
vs S&P+8 pts+4 pts+16 pts+28 pts+12 pts+2 pts+28 pts+22 pts−2 pts−12 pts+119 pts+18 pts+26 pts−16 pts−0 pts+36 pts
n9245638293651312743672630454650

Read the research behind this screen: Price-to-book still sorts, across all sizes → · Test your own combination in the Screen Lab →

Our model values are recomputed daily but were never stored historically, so this band cannot be backtested honestly yet. Daily snapshots began 2026-09-10; a true record accrues from there. Until then the nearest tested cousin is shown — cheap on book value — and labelled as a proxy. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

Sort by: A–Z Riskiest Most overvalued Most shorted Buyers' strike Largest
AMPGZ
AmpliTech Group, Inc.
Deeply undervalued
Technology Risk 34 · Moderate
Price$0.22
Model IV$3.23
P/IV0.20
Discount 93% Return to IV: +1,359.3%
Market implies -50.0%/yr vs model +47.8% · below model
AMPH
Amphastar Pharmaceuticals, Inc.
Deeply undervalued
Healthcare Risk 42 · Elevated
Price$23.78
Model IV$41.98
P/IV0.45
Discount 43% Return to IV: +76.5%
Market implies +1.4%/yr vs model +13.1% · below model
AMPY
Amplify Energy Corp.
Deeply undervalued
Energy Risk 31 · Moderate
Price$4.93
Model IV$13.75
P/IV0.34
Discount 64% Return to IV: +179.0%
Market implies -19.4%/yr vs model +0.0% · below model
AMR
Alpha Metallurgical Resources, Inc.
Deeply undervalued
Energy Risk 37 · Moderate
Price$197.85
Model IV$468.45
P/IV0.42
Discount 58% Return to IV: +136.8%
Market implies -9.5%/yr vs model +3.0% · below model
AMS
AMERICAN SHARED HOSPITAL SERVICES
Deeply undervalued
Healthcare Risk 30 · Moderate
Price$1.47
Model IV$12.41
P/IV0.12
Discount 88% Return to IV: +741.3%
Market implies -50.0%/yr vs model +12.4% · below model
AN
AUTONATION, INC.
Deeply overvalued
Consumer Cyclical Risk 41 · Elevated
Price$203.61
Model IV$142.96
P/IV0.16
Premium +42% Return to IV: -29.8%
Market implies +6.9%/yr vs model +3.6% · above model
ANF
ABERCROMBIE & FITCH CO /DE/
Fairly valued
Consumer Cyclical Risk 42 · Elevated
Price$145.23
Model IV$141.62
P/IV0.55
Premium +3% Return to IV: -2.5%
Market implies +10.5%/yr vs model +12.8% · in line
ANIP
ANI PHARMACEUTICALS INC
Deeply undervalued
Healthcare Risk 38 · Moderate
Price$70.40
Model IV$369.54
P/IV0.21
Discount 81% Return to IV: +424.9%
Market implies -3.8%/yr vs model +25.0% · below model
APA
APA Corp
Deeply undervalued
Energy Risk 35 · Moderate
Price$45.03
Model IV$170.09
P/IV0.21
Discount 74% Return to IV: +277.7%
Market implies -14.3%/yr vs model +3.5% · below model
APO
Apollo Global Management, Inc.
Deeply undervalued
Financial Services Risk 34 · Moderate
Price$128.98
Model IV$428.25
P/IV0.30
Discount 70% Return to IV: +232.0%
Market implies +2.2%/yr vs model +25.0% · below model
APOG
APOGEE ENTERPRISES, INC.
Deeply undervalued
Industrials Risk 43 · Elevated
Price$37.88
Model IV$57.42
P/IV0.67
Discount 34% Return to IV: +51.6%
Market implies -1.2%/yr vs model +7.0% · below model
APPF
APPFOLIO INC
Deeply undervalued
Technology Risk 32 · Moderate
Price$208.48
Model IV$246.59
P/IV0.65
Discount 15% Return to IV: +18.3%
Market implies +15.0%/yr vs model +22.9% · below model
APWC
ASIA PACIFIC WIRE & CABLE CORP LTD
Deeply undervalued
Basic Materials Risk 26 · Moderate
Price$1.36
Model IV$7.10
P/IV0.20
Discount 81% Return to IV: +421.7%
Market implies -22.5%/yr vs model +5.0% · below model
ARAY
ACCURAY INC
Valuation N/A
Healthcare Risk 44 · Elevated
Price$0.25
Model IV—
P/IV—
Market implies -50.0%/yr vs model +3.7% · below model
ARCO
Arcos Dorados Holdings Inc.
Deeply undervalued
Consumer Cyclical Risk 37 · Moderate
Price$8.01
Model IV$32.12
P/IV0.27
Discount 75% Return to IV: +301.0%
Market implies -25.4%/yr vs model +15.2% · below model
ARCT
Arcturus Therapeutics Holdings Inc.
Deeply undervalued
Healthcare Risk 37 · Moderate
Price$14.73
Model IV$50.73
P/IV0.16
Discount 71% Return to IV: +244.4%
Market implies -20.5%/yr vs model +50.0% · below model
ARDT
Ardent Health, Inc.
Deeply undervalued
Healthcare Risk 34 · Moderate
Price$10.98
Model IV$37.62
P/IV0.25
Discount 71% Return to IV: +242.6%
Market implies -12.5%/yr vs model +8.1% · below model
ARE
ALEXANDRIA REAL ESTATE EQUITIES, INC.
Deeply undervalued
Financial Services Risk 33 · Moderate
Price$51.14
Model IV$90.72
P/IV0.55
Discount 44% Return to IV: +77.4%
ARKB
Ark 21Shares Bitcoin ETF
Deeply undervalued
Financial Services Risk 33 · Moderate
Price$26.19
Model IV$41.00
P/IV0.59
Discount 36% Return to IV: +56.5%
ARKR
ARK RESTAURANTS CORP
Deeply undervalued
Consumer Cyclical Risk 34 · Moderate
Price$4.83
Model IV$67.75
P/IV0.09
Discount 93% Return to IV: +1,304.1%
Market implies -50.0%/yr vs model +5.9% · below model
ARLP
ALLIANCE RESOURCE PARTNERS LP
Deeply undervalued
Energy Risk 27 · Moderate
Price$26.14
Model IV$104.69
P/IV0.24
Discount 75% Return to IV: +300.5%
Market implies -12.2%/yr vs model +7.2% · below model
ARR
Armour Residential REIT, Inc.
Valuation N/A
Financial Services Risk 40 · Elevated
Price$15.50
Model IV—
P/IV—
Limited data — see page
ARVN
ARVINAS, INC.
Deeply undervalued
Healthcare Risk 33 · Moderate
Price$8.45
Model IV$26.34
P/IV0.34
Discount 68% Return to IV: +211.7%
Market implies -20.1%/yr vs model +48.8% · below model
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Deeply undervalued
Healthcare Risk 37 · Moderate
Price$82.85
Model IV$22.52
P/IV0.61
Premium +268% Return to IV: -72.8%
Market implies +37.0%/yr vs model +25.0% · above model
ARX
Accelerant Holdings
Deeply undervalued
Financial Services Risk 26 · Moderate
Price$19.84
Model IV$158.51
P/IV0.10
Discount 87% Return to IV: +698.9%
Market implies -7.7%/yr vs model +25.0% · below model
ASC
Ardmore Shipping Corp
Deeply undervalued
Industrials Risk 36 · Moderate
Price$18.67
Model IV$54.00
P/IV0.30
Discount 65% Return to IV: +189.2%
Market implies -6.2%/yr vs model +10.7% · below model
ASPS
ALTISOURCE PORTFOLIO SOLUTIONS S.A.
Deeply undervalued
Technology Risk 48 · Elevated
Price$5.82
Model IV$30.74
P/IV0.21
Discount 81% Return to IV: +428.7%
Market implies -35.5%/yr vs model +2.0% · below model
ATEC
Alphatec Holdings, Inc.
Deeply undervalued
Healthcare Risk 48 · Elevated
Price$10.58
Model IV$33.35
P/IV0.23
Discount 68% Return to IV: +215.2%
Market implies -23.3%/yr vs model +33.1% · below model
ATER
Aterian, Inc.
Deeply undervalued
Technology Risk 30 · Moderate
Price$0.77
Model IV$4.76
P/IV0.23
Discount 84% Return to IV: +515.2%
Market implies -39.8%/yr vs model +2.0% · below model
ATLC
Atlanticus Holdings Corp
Deeply undervalued
Financial Services Risk 26 · Moderate
Price$94.46
Model IV$710.96
P/IV0.12
Discount 87% Return to IV: +652.7%
Market implies -13.9%/yr vs model +25.0% · below model
ATNI
ATN International, Inc.
Deeply undervalued
Communication Services Risk 41 · Elevated
Price$30.32
Model IV$50.28
P/IV0.56
Discount 40% Return to IV: +65.8%
Market implies -2.1%/yr vs model +6.4% · below model
AUPH
Aurinia Pharmaceuticals Inc.
Deeply undervalued
Healthcare Risk 33 · Moderate
Price$16.10
Model IV$42.74
P/IV0.36
Discount 62% Return to IV: +165.5%
Market implies +4.8%/yr vs model +25.0% · below model
AVA
AVISTA CORP
Deeply undervalued
Utilities Risk 30 · Moderate
Price$36.79
Model IV$68.09
P/IV0.61
Discount 46% Return to IV: +85.1%
AVNW
AVIAT NETWORKS, INC.
Deeply undervalued
Technology Risk 37 · Moderate
Price$19.78
Model IV$57.83
P/IV0.31
Discount 66% Return to IV: +192.4%
Market implies -19.3%/yr vs model +12.1% · below model
AXP
AMERICAN EXPRESS CO
Deeply undervalued
Financial Services Risk 38 · Moderate
Price$324.43
Model IV$512.26
P/IV0.62
Discount 37% Return to IV: +57.9%
Market implies +3.9%/yr vs model +12.9% · below model
AYTU
AYTU BIOPHARMA, INC
Deeply undervalued
Healthcare Risk 28 · Moderate
Price$1.99
Model IV$8.17
P/IV0.28
Discount 76% Return to IV: +310.4%
Market implies -30.3%/yr vs model +2.0% · below model
BAER
Bridger Aerospace Group Holdings, Inc.
Deeply undervalued
Technology Risk 45 · Elevated
Price$1.04
Model IV$6.74
P/IV0.35
Discount 85% Return to IV: +548.1%
Market implies -35.2%/yr vs model +38.4% · below model
BAFN
BayFirst Financial Corp.
Deeply undervalued
Financial Services Risk 29 · Moderate
Price$8.75
Model IV$12.76
P/IV0.49
Discount 31% Return to IV: +45.8%
BAH
Booz Allen Hamilton Holding Corp
Deeply undervalued
Industrials Risk 39 · Moderate
Price$75.90
Model IV$236.46
P/IV0.33
Discount 68% Return to IV: +211.5%
Market implies -6.6%/yr vs model +9.5% · below model
BALY
Bally's Corp
Deeply undervalued
Consumer Cyclical Risk 47 · Elevated
Price$9.17
Model IV$37.32
P/IV0.38
Discount 75% Return to IV: +307.0%
Market implies -24.8%/yr vs model +16.5% · below model
BANFP
BANCFIRST CORP /OK/
Deeply undervalued
Financial Services Risk 31 · Moderate
Price$28.29
Model IV$88.27
P/IV0.30
Discount 68% Return to IV: +212.0%
BANL
CBL International Ltd
Deeply undervalued
Consumer Defensive Risk 32 · Moderate
Price$6.30
Model IV$4.76
P/IV0.08
Premium +32% Return to IV: -24.5%
Market implies +8.3%/yr vs model +10.8% · in line
BAOS
Baosheng Media Group Holdings Ltd
Valuation N/A
Technology Risk 46 · Elevated
Price$0.30
Model IV—
P/IV—
Market implies -50.0%/yr vs model +12.0% · below model
BATL
BATTALION OIL CORP
Deeply undervalued
Energy Risk 33 · Moderate
Price$1.34
Model IV$30.03
P/IV0.05
Discount 96% Return to IV: +2,141.0%
Market implies -50.0%/yr vs model +6.2% · below model
BBDC
Barings BDC, Inc.
Deeply undervalued
Unknown Risk 36 · Moderate
Price$8.77
Model IV$15.31
P/IV0.57
Discount 43% Return to IV: +74.5%
Market implies -12.6%/yr vs model -1.7% · below model
BBGI
BEASLEY BROADCAST GROUP INC
Deeply undervalued
Communication Services Risk 51 · Elevated
Price$18.29
Model IV$50.81
P/IV0.29
Discount 64% Return to IV: +177.8%
Market implies -17.7%/yr vs model +2.0% · below model
BBWI
Bath & Body Works, Inc.
Deeply undervalued
Consumer Cyclical Risk 30 · Moderate
Price$18.57
Model IV$54.18
P/IV0.37
Discount 66% Return to IV: +191.8%
Market implies -10.5%/yr vs model +7.0% · below model
BBY
BEST BUY CO INC
Deeply undervalued
Consumer Cyclical Risk 37 · Moderate
Price$90.80
Model IV$65.74
P/IV0.17
Premium +38% Return to IV: -27.6%
Market implies +6.9%/yr vs model +2.7% · above model
BCC
BOISE CASCADE Co
Deeply undervalued
Industrials Risk 39 · Moderate
Price$75.25
Model IV$108.14
P/IV0.17
Discount 30% Return to IV: +43.7%
Market implies -8.4%/yr vs model +0.0% · below model
BCG
Binah Capital Group, Inc.
Deeply undervalued
Financial Services Risk 23 · Moderate
Price$1.28
Model IV$3.08
P/IV0.52
Discount 58% Return to IV: +140.2%
Market implies -11.1%/yr vs model +7.1% · below model
BCIC
BCP Investment Corp
Deeply undervalued
Unknown Risk 45 · Elevated
Price$7.13
Model IV$130.53
P/IV0.06
Discount 95% Return to IV: +1,730.8%
Market implies -47.2%/yr vs model +3.8% · below model
BCO
BRINKS CO
Deeply undervalued
Industrials Risk 37 · Moderate
Price$111.98
Model IV$180.03
P/IV0.58
Discount 38% Return to IV: +60.8%
Market implies +1.3%/yr vs model +9.9% · below model
BCRX
BIOCRYST PHARMACEUTICALS INC
Deeply undervalued
Healthcare Risk 28 · Moderate
Price$8.12
Model IV$50.33
P/IV0.18
Discount 84% Return to IV: +519.8%
Market implies -6.6%/yr vs model +25.0% · below model
BDL
FLANIGANS ENTERPRISES INC
Deeply undervalued
Consumer Cyclical Risk 30 · Moderate
Price$45.42
Model IV$58.00
P/IV0.59
Discount 22% Return to IV: +27.7%
Market implies +2.6%/yr vs model +9.8% · below model
BDTX
Black Diamond Therapeutics, Inc.
Deeply undervalued
Healthcare Risk 36 · Moderate
Price$1.98
Model IV$4.09
P/IV0.54
Discount 52% Return to IV: +106.5%
Market implies -6.3%/yr vs model +10.0% · below model
BFH
BREAD FINANCIAL HOLDINGS, INC.
Deeply undervalued
Financial Services Risk 33 · Moderate
Price$106.37
Model IV$553.61
P/IV0.16
Discount 81% Return to IV: +420.5%
Market implies -21.4%/yr vs model +6.5% · below model
BGI
BIRKS GROUP INC.
Valuation N/A
Consumer Cyclical Risk 34 · Moderate
Price$0.22
Model IV—
P/IV—
Market implies -50.0%/yr vs model +5.6% · below model
BGM
BGM Group Ltd.
Valuation N/A
Healthcare Risk 40 · Elevated
Price$0.26
Model IV—
P/IV—
Market implies -50.0%/yr vs model +2.0% · below model
BGS
B&G Foods, Inc.
Deeply undervalued
Consumer Defensive Risk 50 · Elevated
Price$3.16
Model IV$13.27
P/IV0.31
Discount 76% Return to IV: +320.0%
Market implies -18.3%/yr vs model +2.0% · below model
BGSF
BGSF, INC.
Deeply undervalued
Technology Risk 42 · Elevated
Price$5.15
Model IV$16.89
P/IV0.30
Discount 70% Return to IV: +228.0%
Market implies -25.4%/yr vs model +2.0% · below model